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Body adiposity index (BAI) is documented to exhibit significant relationship with the 
component of metabolic syndromes (MetS
between BAI and serum glucose among postmenopausal women has not been well 
studied. This study was aimed at determining the relationship between BAI and serum 
glycemic level among postmenopausal women. The study 
sectional. Fasting serum glucose was obtained via superficial vein venipuncture after at 
least eight hours of meal and was analysed following standard biochemical procedure. 
Standard techniques for anthropometric measurement 
appropriate parameters. Chi-square was used to determine the relationship between 
body mass index (BMI) and clinically accepted categorical subdivision of fasting blood 
sugar (FBG). A total of 156 postmenopausal women with mean a
years, height (1.58 ± 0.07) m, weight (67.30 ± 17.68) kg, hip circumference (99.94 ± 
12.75) cm, waist circumference (86.56 ± 14.25) cm, BAI (32.61 ± 6.78), BMI (27.05 ± 
6.90) kg/m2 and fasting blood sugar (FBS) (5.21 ± 2.78mmol/L) were 
current study. There was significant positive correlation between BAI and BMI (r = 
0.877, P = 6.97x10-51) and not between BAI and FBG (r = 0.026, P = 0.748). In 
conclusion, BAI was not significantly associated with serum glycemic level amon
menopausal women. 
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INTRODUCTION 
Obesity is a frequent co-morbid condition 
associated with excessive increase in weight 
(Dennis, 2016). During the last century there 
has been numerous changes involving different 
aspect of people’s life style such as changes in 
diet and level of physical activities (
al., 2013). These changes lead to obesity and 
high adiposity which are associated with 
metabolic syndrome, diabetes mellitus (DM) and 
cardiovascular disease (Berentzen et 
Serum glycemic level is the concentration of 
glucose present in the blood (Ross 
Glucose is a simple sugar and approximately 
4 grams of glucose are present in the blood of a 
70-kilogram (150 lb) human at all times 
(Wasserman, 2009). The body tightly 
blood glucose levels as a part of metabolic 
homeostasis and it is stored in skeletal muscle
as well as liver cells in the form of 
(Wasserman, 2009). In fasted individuals, blood 
glucose is maintained at a constant level at the 
expense of glycogen stores in the liver and 
skeletal muscle (Lai et al., 2009). 
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) including serum glucose. The relationship 
design was observational cross 
were used in obtaining the 
ge of 62.70 ± 12.84 
assessed in the 
Berentzen et 
al., 2013)  




Menopause is a normal condition that all women 
experience as they age (Wegienka
2005). The term "menopause" can describe any 
of the changes a woman goes through either 
just before or after she stops menstruating and 
it marks the end of the females reproductive 
period and it is characterized by inability of the 
ovary to release egg every month  (
al., 2009). A woman is born with a finite number 
of eggs, which are stored in the ovaries in which 
estrogen and progesterone hormones that 
control menstruation and ovulation
(Caldwell et al., 2007; Eliyas, 2017
menopause is characterized by a decrease in th
level of estrogen hormone in addition to the 
menopausal feature of complete cessation of 
ovulation and menstrual cycles (Davidson 
2011). 
Physiologically, estrogen stimulate fatty acid 
catabolism and so the postmenopausal decrease 
in postmenopausal decrease in estrogen leve
causes an accumulation of fatty acid, especially 
in the area of the abdomen which is described 
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The increased incidence of diabetes, 
cardiovascular disease, and osteoporosis among 
post-menopausal women has also been 
postulated to be related to the low levels of 
estrogen in them (Rouen, 2009). 
Diabetes mellitus (DM) which is characterized by 
persistently high blood glucose level is a major 
cause of morbidity and mortality worldwide. The 
relationship between the body adiposity index 
(BAI) with blood glucose has not been well 
studied in worldwide, especially among 
postmenopausal women. Risk of diabetes 
mellitus may increase in older age groups and 
since postmenopausal women constitute a good 
number of people in the older age, exploring 
more anthropometric tools for estimating risk of 
DM is justified. The study may identify a 
relationship between BAI which is an 
inexpensive anthropometric feature and blood 
glucose level among postmenopausal women. 
Thus, this can find great use in the clinics for the 
assessment of diabetes risk among post-
menopausal women. The aim of the study was 
to determine the relationship between body 
adiposity index and serum glucose level among 
post-menopausal women in Murtala Muhammad 
Specialist Hospital.  
 
MATERIALS AND METHODS 
Study design 
The study was a cross sectional observational 
study. Consecutive sampling technique was used 
for subject selection.  The study was conducted 
at the medical laboratory of Murtala Muhammad 
Specialist Hospital, Kano Nigeria. This hospital 
was chosen because of the large number of 
patients that are reviewed every day because it 
is one of the largest and affordable health 
facility in the state. The inclusion criteria 
included any postmenopausal (cessation of 
monthly period >12 consecutive months) female 
subjects attending MMSH as outpatients who 
gave an informed consent to participate in the 
study. An introductory letter was obtained from 
the department of Human Anatomy which 
accompanied the research proposal to the ethics 
committee of the state ministry of health. Ethical 
approval was obtained before the 
commencement of the study. 
 
Anthropometric measurements and indices 
Height was measured to the nearest 0.1cm as 
the vertical distance between the surface on 
which the participant was standing erect without 
shoes and the vertex of the head using a 
stadiometer (Price et al., 2006). Body weight 
was measured in kilograms using a weighing 
scale while the subject was in light clothing and 
standing erect on the weighing scale (Mueller et 
al., 1991). Hip circumference (HC) was 
measured using an un-stretchable measuring 
tape with an accuracy to the nearest 0.1 cm at 
the level of the maximum extension of the 
buttocks posteriorly in a horizontal plane, 
without compressing the skin (Sebo et al., 
2015). 
The body adiposity index (BAI) was calculated 
using the equation suggested by Bergman et al., 
(2011) BAI= ((hip circumference (cm)) / 
((height (m))1.5)-18). 
 
Measurement of Biochemical parameters 
Fasting blood samples were obtained via 
superficial vein venipuncture after 8 h of fasting. 
Serum glucose was measured in the laboratory 
using Active Accucheck glucometer®. 
 
Statistical Analysis 
Data were presented as mean ± standard 
deviation. Categorical variables were expressed 
as frequency and percentage. Statistical package 
for social science (SPSS) version 22 was used for 
statistical analysis and P<0.05 was considered 
significant. Pearson correlation and chi-square 
test were used for correlation between serum 
glycemic level, body adiposity index and body 
mass index depending on whether the data was 
continuous or categorical data, respectively.  
 
RESULTS 
The mean values for age (62.70 years), height 
(1.58 m), hip circumference (99.94 cm), weight 
(67.30 kg), fasting blood sugar (5.21 mmol/L), 
body mass index (27.05 kg/m2), Body adiposity 
index (32.61), waist circumference (86.56 cm) 
are presented in Table 1. The correlation 
between the different parameters measured in 
quantitative values were evaluated using 
Pearson’s correlational statistics and the result 
were presented in Table 2. 
The correlation between weight, HC, BMI, BAI 
and WC were high as well as statistically 
significant. The correlation between weight and 
BMI (r = 0.953),weight and HC (r = 0.909), and, 
HC and BMI (r = 0.908) respectively, were the 
strongest among all the positive correlations that 
were statistically significant and these were 
followed by the correlation between HC and BAI 
(r = 0.897), BMI and BAI (r = 0.877), BMI and 
WC (r = 0.861), weight and WC (r = 0.858), 
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Table 1: Measures of central tendency for age, blood glucose level and measurements of 
anthropometric features among postmenopausal women  
Variables                    Minimum Maximum Mean ± SD 
Age (years) 46 105 62.70±12.84 
Height (m) 1.41 1.80 1.58±0.07 
HC (cm) 65.5 133.0 99.94±12.75 
Weight (kg) 30.60 116.60 67.30±17.68 
FBG (mmol/L) 2.90 29.50 5.21±2.78 
BMI 12.41 49.17 27.05±6.90 
BAI 16.91 52.93 32.61±6.78 
 WC 59.0 122.0 86.56 ± 14.25 
 HC=Hip circumference, FBG= Fasting blood glucose, BMI=Body mass index, BAI=Body adiposity 
index, SD=Standard deviation, WC= Waist circumference n=156 
 
Table 2: Correlation between some anthropometric parameters, age and blood glucose levels of the 
study participants (n=156)  
 WEIGHT(kg) HC (cm) HEIGHT(m) FBG(mmol/
L) 
BMI BAI AGE WC(c
m) 
WEIGHT(kg) 1        
HC (cm) 0.909** 1       
HEIGHT(m) 0.276** 0.137 1      
FBG(mmol/L) -0.072 0.085 -0,131 1     
BMI 0.953** 0.908** -0,020 -0.039 1    
 BAI 0.744** 0.897** -0.312** -0.026 0.877** 1   
 AGE -0.244** -0.276** -0.161* 0.000 0.210** -0.191* 1  
 WC(cm) 0.858** 0.813** 0.079 -0.020 0.861** 0.735** 0.166 1 
**correlation is significant at 0.01, *. Correlation is significant at the 0.05 level, FBG= fasting blood 
glucose, BMI= body mass index, BAI= body adiposity index, HC= Hip circumference, WC= waist 
circumference 
 
When the correlational assessment for BMI and 
BAI was carried out based on the clinically 
defined categories of FBG, the association 
became stronger for categories of normal (non- 
diabetics) (r = 0.884) and diabetic patients (r = 
0.920) (Table 3). In addition, when the same 
evaluation was carried out based on clinically 
defined categories of BMI it was only the normal 
and obese BMI categories that had a statistically 
significant correlation with the latter stronger 
than the former (Table 4). Thus, suggesting that 
the correlation between BAI and BMI was 
strongest among obese persons that have 
diabetes level of FBG. The persons with normal 
BMI weighingpersons that are categorized as 
having prediabetes level of FBG also have a 
strong correlation between BAI and BMI.The 
correlation between BAI and FBG, as well as that 
of BMIand FBG were not statistically 
significant(P≥0.05) and these results remained 
same even after reevaluating the quantitative 
Pearsons correlation based on clinically 
described categories of fasting blood glucose as 
well as BMI (Tables 5 and 6). The evaluation of 
the association between BMI (four and two) 
categories and FBG (two) categories by the use 
of Chi square was also not statistically significant 
(Table 7). 
  
Table 3: Pearson correlation between BAI and BMI when data is categorized according to clinical 
definition of FBG of the participants recruited at MMSH (n=156)  
FBG Categories Variables R P 
Normal BAI 0.884** 0.000 
 BMI   
Prediabetes BAI 0.728** 0.000 
 BMI   
Diabetes BAI 0.920** 0.000 
 BMI   
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Table 4: Pearson correlation between BAI and BMI based on the different categories of BMI among 
participants recruited at MMSH 
BMI Categories Variables r- value p- value 
Underweight BAI 0.213 0.396 
 BMI   
Normal BAI 0.430** 0.003 
 BMI   
Overweight BAI 0.248 0.089 
 BMI   
Obese BAI 0.678** 0.000 
 BMI   
**. Correlation is significant at the 0.01 level (2-tailed), BAI=Body adiposity index, BMI=Body mass 
index, (n=156)
 
Table 5: The Pearson correlation between body adiposity index and fasting blood glucose when data 
is categorized according to different clinical definitions offasting blood glucose(n=156) 
FBG Categories Variables r- value p- value 
Normal BAI 0.025 0.787 
 FBG   
Prediabetes BAI -0.022 0.929 
 FBG   
Diabetes BAI -0.274 0.304 
 FBG   
Normal BAI 0.025 0.787 
 FBG   
Abnormal BAI -0.216 0.213 
 FBG   
BAI=Body adiposity index FBG=Fasting blood glucose, Abnormal FBG category is made up of 
Prediabetes and diabetes categories of particpants 
 
Table 6: The Pearson correlation between body adiposity index and fasting blood glucose based on 
different categories of body mass index (underweight, normal weight, overweight and obese) among 
the participants 
BMI Categories Variables r- value p- value 
Under weight BAI 0.385 0.115 
 FBG    
Normal weight BAI -0.124 0.417 
 FBG   
Over weight BAI -0.108 0.465 
 FBG   
Obese BAI -0.093 0.542 
 FBG   
BAI=Body adiposity index FBG=Fasting blood glucose, (n=156) 
 
Table 7: The association between body mass index (four and two categories) and fasting blood 
glucose (two categories) among postmenopausal women  
BMI Categories                                              FBG Categories Total   x2 df    p 
 Normal Abnormal     
Underweight          14     4   18    
Normal          38     7   45    
Overweight          37     11   48 2.308 3  0.511 
Obese          32     13   45    
Total          121     35   156    
       
Normal          38    6    44    
Abnormal          83   29    112  2.727 1 0.099 
Total         121       35    156    
BMI= Body mass index, FBG= Fasting blood glucose, n=156 
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The observation from the present study that the 
mean BMI and BAI of the participant were 27.05 
± 6.90 and 32.61 ± 6.78 is similar to the reports 
from an earlier study among postmenopausal 
Caucasian, African American and Filipina women 
(Djeneba et al., 2014). It was also observed that 
the mean FBG was 5.21 ± 2.78 which is within 
the expected range as reported in a previous 
study among participants of Hausa ethnic group 
in Kano, Nigeria (Asuku et al., 2017). The 
current study evaluated the utility of BAI as a 
measure of adiposity and the analyses revealed 
that BAI was significantly correlated with other 
(waist circumference, hip circumference and 
BMI) anthropometric measures of adiposity. An 
earlier study demonstrated that BAI could be 
used to determine the fat content in patient with 
adipose tissue scarcity, such as individual with 
familial partial lipodystophy, thus emphasizing 
on the correlational finding in the current study 
(Godoy-Matos et al., 2012).
The percentage of total adipose tissues 
measured by Dual energy X-ray Absorptiometry 
was more strongly correlated with BAI than BMI, 
which themselves are also correlated (Godoy-
Matos et al., 2012). Another study attempted to 
validate the relationship between BAI and 
anthropometric parameters among Asians and it 
was identified that ethnic differences in the level 
of correlation with the hip circumference and 
height exist (Zhao et al., 2013).  
The results of the current study revealed that 
BAI and BMI were significantly correlated 
(P≤0.05). This result is similar to that of an 
earlier study that the body adiposity index was 
correlated with body mass index observed 
among postmenopausal Caucasian, African 
American, and Filipina women (Djeneba et al., 
2014).Another study also reported that BMI was 
a better tool for predicting body adiposity in 
Korean women (Yeon-Ahet al., 2014). 
Nevertheless, the current study identified that 
the strength of correlation was highest among 
obese post- menopausal women that have a 
diabetes level of FBG and this was putatively a 
novel finding. 
There was no correlation between FBG and BAI 
in this study irrespective of the BMI as well as 
the FBG category of the patient evaluated. This 
result was not similar to the finding in the 
literature in which BAI had a weak correlation 
with FBG (Asuku et al., 2017). BAI also had a 
weak correlation with fasting glucose when 
compared to the correlation values with other 
indices of adiposity (Nobrega et al., 2012). This 
literature findings are in sharp contrast to the 
finding in the current study as well as another 
literature report that revealed that the 
percentage change in BAI following weight loss 
had been significantly associated with 
percentage change in leptin, but not with 
percentage change in fasting blood glucose 
(Elisha et al., 2013). These differences may be 
explained by difference in Ethnic origin of the 
study population.   
Conclusion:  
It can be concluded from the present study that 
the mean BAI, BMI and FBG of the 
postmenopausal women studied were similar to 
those reported in earlier studies. There was no 
relationship between BAI and FBG. However, 
there was a positive statistically significant (P < 
0.05) correlation (r = 0.877) between BMI and 
BAI.   
 
RECOMMENDATION 
• A larger sample study involving community 
and hospital-based population recruited via 
simple random approach to eliminate any 
bias should be studied to validate the 
findings of the present study. 
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